Please login to the form below

Not currently logged in
Email:
Password:

Vifor

This page shows the latest Vifor news and features for those working in and with pharma, biotech and healthcare.

ChemoCentryx surges on phase 3 vasculitis study

ChemoCentryx surges on phase 3 vasculitis study

The positive results set up regulatory filings in both the US and Europe next year, according to  ChemoCentryx, which has licensed ex-US rights to Switzerland’s Vifor Fresenius Medical Care ... Renal Pharma (VFMCRP), a joint venture between Vifor

Latest news

More from news
Approximately 5 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Under the original licence Vifor's rights covered Europe, Canada, Mexico, Central and South America and South Korea. ... In return for the expanded territory, Vifor is paying ChemoCentryx $20m upfront and tiered double digit royalties on potential net

  • Deal Watch July 2016 Deal Watch July 2016

    Galenica, the Swiss healthcare company that is preparing itself for a split into two parts, Vifor Pharma (healthcare product development, manufacturing and marketing) and pharmacy and wholesaler service provider, has acquired ... The Vifor division,

  • Deal Watch May 2016 Deal Watch May 2016

    The presence of the CRL on the books however did not deter Vifor Fresenius Medical Care Renal Pharma's decision to license Rayaldee [a vitamin D prohormone treatment] from OPKO paying ... 293. OPKO Health/ Vifor Fresenius. Licence. Rayaldee in EP, CA,

  • Pharma deals in August 2015 Pharma deals in August 2015

    Collaboration. 219. Relypsa. Vifor Fresenius. Patiromer oral suspension in treating hyperkalemia.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Hansa Medical poaches Vifor Pharma’s CEO Hansa Medical poaches Vifor Pharma’s CEO

    Tulstrup was most recently CEO of Swiss pharmaceutical group Vifor Pharma and prior to this he served as senior vice president, global franchise head at Shire.

  • Swiss biotech Inositec appoints new chief medical officer Swiss biotech Inositec appoints new chief medical officer

    Dr van Alphen joins from Roche, where he headed its operational excellence team and prior to this he was chief medical officer at Vifor Pharma, head of medical affairs Europe at

  • Galenica Group strengthens management team Galenica Group strengthens management team

    Appoints Stefan Schulze, Felix Burkhard and Jörg Kneubühler. Stefan Schulze has been appointed as chief operating officer and president of the executive committee of Vifor Pharma, part of the Switzerland-based ... We opted for these variant because of

  • Lupin appoints Thierry Volle president for EMEA Lupin appoints Thierry Volle president for EMEA

    He moves to the company from Vifor. Mumbai-based pharma company Lupin has appointed Thierry Volle to lead its Europe, Middle-East and Africa operations as president. ... He joins the firm from Vifor Pharma, where he was the head of EU and International

  • Verona names David Ebsworth as non-executive chairman Verona names David Ebsworth as non-executive chairman

    He joins from Vifor Pharma. Verona Pharma has appointed Dr David Ebsworth as its non-executive chairman of the board of directors. ... He most recently served as CEO at Vifor Pharma and was also named CEO of Galenica in 2011, continuing to be an adviser

More from appointments
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • EPG Health EPG Health

    Novartis, Orphan Europe, Philips, Pfizer, Roche, Sanofi, Takeda, UCB, Uriach, Vifor Pharma.

  • IGNIFI IGNIFI

    Nike. Novartis. PGT Healthcare. Smith and Nephew. Theramex. Veriton Pharma. Vifor Pharma.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics